Cargando…
Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1
To achieve a cure for metastatic breast cancer, further understanding of molecular drivers of the metastatic cascade is essential. Currently, chemotherapy regimens include doxorubicin and paclitaxel which act in part by inducing the unfolded protein response (UPR). The master regulator of the UPR, g...
Autores principales: | Raiter, Annat, Lipovetsky, Julia, Hyman, Lucila, Mugami, Shany, Ben-Zur, Tali, Yerushalmi, Rinat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518037/ https://www.ncbi.nlm.nih.gov/pubmed/33042795 http://dx.doi.org/10.3389/fonc.2020.01500 |
Ejemplares similares
-
Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer
por: YERUSHALMI, RINAT, et al.
Publicado: (2015) -
Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells
por: Raiter, Annat, et al.
Publicado: (2014) -
GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment
por: Raiter, Annat, et al.
Publicado: (2020) -
A novel role for an old target: CD45 for breast cancer immunotherapy
por: Raiter, Annat, et al.
Publicado: (2021) -
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor
por: Raiter, Annat, et al.
Publicado: (2023)